Phacetoperane

From Wikipedia, the free encyclopedia

Phacetoperane
Systematic (IUPAC) name
[(R)-Phenyl-[(2R)-piperidin-2-yl]methyl] acetate
Identifiers
CAS number 24558-01-8
ATC code  ?
PubChem 65715
Chemical data
Formula C14H19NO2 
Mol. mass 233.31 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Phacetoperane (Levofacetoperane) is a stimulant drug.[1] It is the reverse ester of the well known stimulant drug methylphenidate, which is used as a treatment for ADHD. The reverse esters of many drugs which contain an ester group in their structure such as pethidine and cocaine, show similar activity to the parent compound.[2]

Phacetoperane was researched for similar applications to methylphenidate, but was never marketed. The levo-isomer Levophacetoperane seems to have been more researched, but presumably the dextro isomer or racemic mix are also known.[3]


[edit] References

  1. ^ Delbeke FT, Debackere M. Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping. I. Gas chromatographic detection procedure with electron capture detection for some secondary amines. Journal of Chromatography. 1975 Mar 26;106(2):412-7.
  2. ^ Janssen PAJ, Eddy NB. Compounds Related to Pethidine - IV. New General Chemical Methods of Increasing the Analgesic Activity of Pethidine. Journal of Medicinal and Pharmaceutical Chemistry. 1960; 2(1): 31-45.
  3. ^ Beaujard M, Revol E. Clinical tests of the activity of RP 8228 (phacetoperane) in an oligophrenic child. (French) Pediatrie. 1960;15:310-6.